title: Whither the modulation of platinum?
authors.affiliation: Division of Cancer Treatment, National Cancer Institute, Bethesda, MD 20892.
authors.forename: B
authors.initials: B
authors.lastname: Leyland-Jones
mesh_terms: D004999:Amifostine / Q000494:pharmacology; D000963:Antimetabolites / Q000494:pharmacology; D019328:Buthionine Sulfoximine; D002945:Cisplatin / Q000009:adverse effects*; D004050:Ditiocarb / Q000494:pharmacology; D006801:Humans; D008717:Methionine Sulfoximine / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D000963:Antimetabolites; D008717:Methionine Sulfoximine; D019328:Buthionine Sulfoximine; D004050:Ditiocarb; D004999:Amifostine; D002945:Cisplatin